Molecular Diagnostics a Natural Fit for Breast Cancer
The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.
The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
According to the American Heart Association, approximately 325,000 people per year die of a heart attack before they can reach a hospital.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Could the same hormone that regulates your appetite keep you from developing Alzheimer’s?
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Copyright © 2026 | WordPress Theme by MH Themes